The U.S vacuum blood collection tubes market is experiencing growth as a result of rising demand for accurate, efficient, and standardized procedures for blood collection in hospitals, clinical laboratories, diagnostic centers, and research organizations. Vacuum blood collection tubes are known to enable contamination free collection of blood samples, standardization of blood volume, and efficient laboratory processes. Prevalence of chronic diseases, increasing test volumes, growth of healthcare infrastructure, and improvements in tube material, safety, and automation compatibility are among the factors driving increased usage of vacuum blood collection tubes in the United States.
According to SNS Insider, the U.S. Vacuum Blood Collection Tube Market was valued at USD 0.86 billion in 2025 and is expected to grow to USD 1.19 billion by 2035, registering a CAGR of 3.28% during the period from 2026 to 2035. The global market was estimated to be worth USD 3.28 billion in 2025 and is expected to reach USD 4.94 billion by 2035, growing at a CAGR of 4.18%. Factors such as rising demand for safe and accurate blood sampling, increasing demand for tests for chronic diseases, growing test volumes, and adoption of advanced technology in tubes are contributing to growth in the US.
Gain Actionable Intelligence on this Market – Request a Free Sample Report
Diagnostic Testing and Laboratory Automation Are Shaping U.S. Blood Collection Tube Demand
The North America region held the largest share of 40.50% in the Vacuum Blood Collection Tube Market in 2025 owing to advanced healthcare infrastructure, high adoption rate of automated blood collection system, and presence of major diagnostic and laboratory equipment manufacturers. The United States is emerging as one of the significant contributors owing to increased adoption of efficient and standardized blood collection systems by hospitals and laboratories in the region. Demand for accuracy in clinical diagnosis, increased volume of diagnostic tests, and use of blood collection tubes in automated analyzers are contributing towards the growth of the market in the region.
Serum Separator Tubes held around 34.8% of the product type segment and were the most prominent among the product types as they provide rapid and efficient separation of serum from whole blood. The EDTA Tubes are showing fastest growth due to increased usage in hematology, molecular testing, and special blood analysis. Anticoagulants held around 46.2% of the additive type segment owing to their high usage in prevention of blood clotting for hematology, coagulation, and molecular analysis, while Gel Separators are witnessing fast growth due to their high sample integrity and contamination reduction capability.
The Clinical Diagnostics market made up around 57.4% of the application market because of the wide adoption of vacuum blood collection tubes for blood analysis, disease diagnostics, and patient portal. The research & academic laboratories market is growing at a rapid pace because of the rising need for accurate sample collection in biomedicine, pharmacology, and molecular biology. Around 43.9% of the end-user market was occupied by diagnostic laboratories because of the need for high volume of blood tests, whereas the market share for blood collection centers is rising on account of increasing blood donation activities.
Companies Supporting U.S. Blood Collection and Diagnostic Efficiency
Becton, Dickinson and Company (BD)
Becton, Dickinson and Company (BD) is a world-renowned medical technology company that specializes in the production of medical devices, laboratory instruments, and diagnostics, including vacuum blood collection tubes. BD's emphasis is on innovation, safety, and workflow efficiency. The company produces products aimed at improving blood collection accuracy and reducing the risk of contamination and enhancing safety for patients and healthcare workers. In June 2024, BD introduced the BD Vacutainer Plus range with Eco-Safe Tubes made of 30% less plastic and stoppers without chlorine, along with BD One Digital ID, which is a 2D Data Matrix code on each tube for pre-analytical traceability.
Terumo Corporation
Terumo Corporation is a world-leading healthcare company that offers a wide variety of medical devices, including vacuum blood collection tubes. Terumo Corporation emphasizes innovation, safety, and quality to improve clinical outcomes through its blood collection products that ensure sample integrity, contamination reduction, and workflow optimization. In November 2023, Terumo Corporation introduced the Vacuum Integrity Indicator for its Terumo Blood Collection Tubes.
Greiner Bio-One International GmbH
Greiner Bio-One International GmbH is one of the leading producers of laboratory and diagnostic products, such as vacuum blood collection tubes. This firm focuses on precision, reliability, safety, and sample integrity while promoting efficiency in blood sampling and laboratory processes. On February 2025, Greiner Bio-One introduced VACUETTE 360° Traceability, which features QR codes placed on vacuum blood collection tubes that link to a cloud-based platform providing lot tracking, compliance documents, and CO₂ footprint information.
U.S. Vacuum Blood Collection Tube Market Outlook Through 2035
The U.S. Vacuum Blood Collection Tubes Market is estimated to witness steady growth during the forecast period till 2035 on account of increasing diagnostic procedures, increasing incidences of chronic diseases management, improvements in healthcare infrastructure, and increasing demands for safe and efficient blood sampling procedures. The use of automated laboratories, safety innovations, advanced coatings in blood collection tubes, additive optimization, and sample preservation technologies will also be supportive for market growth.
With the U.S. Vacuum Blood Collection Tubes Market growing to USD 1.19 billion by 2035, increasing demand will be in the form of standardized sample collection systems, advanced safety measures, automation-compatible blood collection tubes, improved sample preservation, and traceability innovations. Technologically advanced blood collection tube systems supplied by manufacturers will also play an important role in the growth of the U.S. diagnostic and laboratory market.
